All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
Complement C2 is a protein that in humans is encoded by the C2 gene. The protein encoded by this gene is part of the classical pathway of complement system, acting as a multi-domain serine protease. The complement system is a group of proteins that work together to destroy foreign invaders (such as bacteria and viruses), trigger inflammation, and remove debris from cells and tissues. When a foreign invader is detected, the complement pathway is turned on (activated) and the complement component 2 protein attaches (binds) to a similar protein called complement component 4. Together, these proteins form a complex called C3 convertase, which triggers further activation of the pathway, allowing the proteins of the complement system to participate in an immune response. Deficiency of C2 has been associated with certain autoimmune diseases.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-T-1-M304-2 | Anti-C2 scFv m(CD28) CART, pCDCAR1 | Human | XHM75 | Mouse | scFv-CD28 | Lentiviral | T cell | ||
CAR-T-1-M304-G | Anti-C2 scFv m(FcεRIγ) CART, pCDCAR1 | Human | XHM75 | Mouse | scFv-FcεRIγ | Lentiviral | T cell | ||
CAR-T-1-M304-Z | Anti-C2 scFv m(CD3ζ) CART, pCDCAR1 | Human | XHM75 | Mouse | scFv-CD3ζ | Lentiviral | T cell | ||
CAR-T-2-M304-2G | Anti-C2 scFv m(CD28-FcεRIγ) CART, pCDCAR1 | Human | XHM75 | Mouse | scFv-CD28-FcεRIγ | Lentiviral | T cell | ||
CAR-T-2-M304-2Z | Anti-C2 scFv m(CD28-CD3ζ) CART, pCDCAR1 | Human | XHM75 | Mouse | scFv-CD28-CD3ζ | Lentiviral | T cell | ||
CAR-T-2-M304-4G | Anti-C2 scFv m(CD4-FcεRIγ) CART, pCDCAR1 | Human | XHM75 | Mouse | scFv-CD4-FcεRIγ | Lentiviral | T cell | ||
CAR-T-2-M304-4Z | Anti-C2 scFv m(CD4-CD3ζ) CART, pCDCAR1 | Human | XHM75 | Mouse | scFv-CD4-CD3ζ | Lentiviral | T cell | ||
CAR-T-2-M304-8Z | Anti-C2 scFv m(CD8-CD3ζ) CART, pCDCAR1 | Human | XHM75 | Mouse | scFv-CD8-CD3ζ | Lentiviral | T cell | ||
CAR-T-2-M304-BZ | Anti-C2 scFv m(41BB-CD3ζ) CART, pCDCAR1 | Human | XHM75 | Mouse | scFv-41BB-CD3ζ | Lentiviral | T cell | ||
CAR-T-2-M304-CZ | Anti-C2 scFv m(b2c-CD3ζ) CART, pCDCAR1 | Human | XHM75 | Mouse | scFv-b2c-CD3ζ | Lentiviral | T cell | ||
CAR-T-3-M304-2BZ | Anti-C2 scFv m(CD28-41BB-CD3ζ) CART, pCDCAR1 | Human | XHM75 | Mouse | scFv-CD28-41BB-CD3ζ | Lentiviral | T cell | ||
CAR-T-3-M304-2XZ | Anti-C2 scFv m(CD28-OX40-CD3ζ) CART, pCDCAR1 | Human | XHM75 | Mouse | scFv-CD28-OX40-CD3ζ | Lentiviral | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION